High-Purity (S)-4-(1-Aminoethyl)benzoic Acid: Expert Manufacturer & Supplier for Pharmaceutical Intermediates

Discover the critical role of (S)-4-(1-Aminoethyl)benzoic acid in advancing pharmaceutical research. As a leading manufacturer and supplier in China, we provide high-purity chiral building blocks essential for API synthesis. Get a reliable quote and sample for your R&D needs.

Get a Quote & Sample

Advantages of Sourcing (S)-4-(1-Aminoethyl)benzoic Acid from Us

Uncompromised Purity for Superior API Synthesis

Our (S)-4-(1-Aminoethyl)benzoic acid boasts a purity of >97.0% (HPLC), ensuring that your pharmaceutical syntheses proceed with high precision and yield. This dedication to purity makes us a preferred supplier for critical R&D applications.

Expertise in Chiral Intermediates

As specialists in chiral synthesis, we understand the nuanced requirements of pharmaceutical intermediates. Trust our capabilities as a manufacturer to deliver the quality you need when you buy chiral building blocks.

Reliable Supply Chain & Competitive Pricing

We pride ourselves on being a dependable supplier in China, offering competitive prices and a stable supply chain for (S)-4-(1-Aminoethyl)benzoic acid. Secure your research materials by purchasing from a trusted source.

Key Applications of (S)-4-(1-Aminoethyl)benzoic Acid

Pharmaceutical Synthesis

This chiral amino acid derivative is instrumental as a building block in the synthesis of Active Pharmaceutical Ingredients (APIs), enabling the creation of complex therapeutic molecules.

Organic Chemistry Research

Researchers in organic chemistry widely utilize (S)-4-(1-Aminoethyl)benzoic acid for various synthetic pathways, exploring new chemical entities and reactions.

API Intermediates Manufacturing

As a key intermediate, it plays a crucial role in the large-scale manufacturing of APIs, contributing to the efficient production of pharmaceuticals.

Drug Discovery and Development

Its unique chiral structure makes it a valuable tool for drug discovery programs, facilitating the development of novel drug candidates with specific biological activities.